Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP compliant, guideline study, available as unpublished report, no restrictions, fully adequate for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1994
Report date:
1994

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EPA OTS 798.5395 (In Vivo Mammalian Cytogenics Tests: Erythrocyte Micronucleus Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
4-vinylcyclohexene
EC Number:
202-848-9
EC Name:
4-vinylcyclohexene
Cas Number:
100-40-3
Molecular formula:
C8H12
IUPAC Name:
4-vinylcyclohexene
Details on test material:
- Name of test material (as cited in study report): 4-vinylcyclohexene
- Batch No: #1
- Supplied by: Union Carbide Corporation, Institute, WV, USA
- Analytical purity: 99.8 (supplied), 99.6-99.7% (reanalysis)
- 4-tertbutylcatechol present as inhibitor

Test animals

Species:
mouse
Strain:
B6C3F1
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Breeding laboratories (B6C3F1/CrlBR)
- Age at study initiation: approximately 5 weeks
- Weight at study initiation: 16-25 g (males), 13-20 g (females) at approximately 24 days old
- Assigned to test groups randomly: using a computerised, stratified randomisation program
- Fasting period before study: no
- Housing: individually housed in in stainless steel wire-mesh cages (except during exposure)
- Diet: Purina Certified Rodent Chow (chunk) #5002 ad libitum (except during exposure)
- Water: tap water ad libitum (except during exposure)
- Quarantine period: 2 weeks

ENVIRONMENTAL CONDITIONS
- Temperature: target 23±2°C
- Humidity: target 55±15%
- Air changes (per hr): no data
- Photoperiod: 12 hrs dark / 12 hrs light

IN-LIFE DATES: 26 January 1993 to 28 May 1993

Administration / exposure

Route of administration:
inhalation
Vehicle:
air
Details on exposure:
TYPE OF INHALATION EXPOSURE: whole body

GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: stainless steel and glass with a nominal volume of 150 or 300 L
- Method of holding animals in test chamber: within stainless steel cage modules inside the exposure chamber
- System of generation: The exposure chambers operated in a one-pass, flow-through mode. VCH was vaporised by metering VCH into a glass heated flask. The vapour produced was diluted with filtered air to give the desired concentrations for each of the 4 VCH chambers.
- Temperature, humidity, pressure in air chamber: target of 23±2°C, 40-60%, pressure not reported
- Air flow rate: approximately 40 L/min for the 150 l chambers and 60-70 L/min for the 300 L chambers
- Method of particle size determination: not applicable
- Treatment of exhaust air: Passed through a carbon bed prior to venting through a roof exhaust system

TEST ATMOSPHERE
- Brief description of analytical method used: GC-FID (at approximately 30 min intervals throughout exposure)
- Samples taken from breathing zone: yes
Duration of treatment / exposure:
13 week
Frequency of treatment:
6hours/day, 5 days/week
Post exposure period:
approximately 24 hours
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
0, 50, 250, 1000 ppm
Basis:
other: target concentration
Remarks:
Doses / Concentrations:
0, 53 (9.7), 250 (27), 1000 (80) ppm
Basis:
analytical conc.
(SD)
No. of animals per sex per dose:
5
Control animals:
yes, sham-exposed
Positive control(s):
1,3-butadiene
- Route of administration: whole body inhalation
- Doses / concentrations: 1000 ppm
- Analytical purity: 99.9% (composition unchanged over course of study)
- 4-tertbutylcatechol present as inhibitor

Examinations

Tissues and cell types examined:
bone marrow erythrocytes
Details of tissue and slide preparation:
TREATMENT AND SAMPLING TIMES (in addition to information in specific fields): Mice killed by CO2 inhalation and bone marrow smears prepared from the femurs.

DETAILS OF SLIDE PREPARATION: at least 2 slides/animal, fixed in methanol, stained with acridine orange in phosphate buffer (pH7.4)

METHOD OF ANALYSIS: Cell preparations examined with incident light fluorescence microscopy.
Evaluation criteria:
Proportion of PCEs out of 1000 erythrocytes (PCE frequency) and proportion of MN PCEs among 1000 PCEs (MN frequency) determined.
Statistics:
Data transformed using arcsin square root transformation. Normal distribution - parametric methods used, if not - non-parametric methods (Kruskal-Wallis and Mann-Whitney U tests used).

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
yes
Vehicle controls validity:
valid
Positive controls validity:
valid

Any other information on results incl. tables

Mortality, clinical signs and bodyweight: At 1000 ppm all males and three females died. Tremors and lethargy present in 1 male and 2 females at 50 ppm but no clinical signs at 250 ppm. Statistically significant decrease in bodyweight gain in females at 250 ppm over duration of study.

 

Micronucleus assessment: No statistically significant reductions in PCE frequency nor any increases in MN frequency in any 4-vinylcyclohexene groups compared to controls. There was a statistically significant increase in MN frequency in the positive control group.

 

Mean PCE frequency

Concentration(ppm)

Mean PCE frequency % (SD)

Males

Females

0

55.1 (49.8, 60.3)

59.8 (48.5, 70.6)

50

57.5 (47.8, 66.9)

59.4 (50.4, 68.1)

250

54.9 (49.6, 60.1)

60.2 (53.2, 67.1)

1000

no data

63.2 (47.5, 77.5)

Positive control (1000 ppm 1,3-butadiene)

61.1 (48.1, 73.4)

72.3 (64.8, 79.2)

 

Mean MN PCE frequency

Concentration(ppm)

Mean MN PCE frequency % (SD)

Males

Females

0

0.14 (0.00, 0.50)

0.10 (0.00, 0.35)

50

0.24 (0.12, 0.41)

0.14 (0.01, 0.43)

250

0.33 (0.12, 0.66)

0.23 (0.11, 0.39)

1000

no data

0.19 (0.00, 3.58)

Positive control (1000 ppm 1,3-butadiene)

1.56 (0.24, 3.98)

1.67 (1.29, 2.10)

 

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative
4-vinylcyclohexene did not cause any apparent physiological or toxic effects on the bone marrow or induce chromosomal or spindle damage in the nucleated erythroblast cells.
Executive summary:

In a mouse micronucleus assay, 4-vinylcyclohexene did not cause any apparent physiological or toxic effects on the bone marrow or induce chromosomal or spindle damage in the nucleated erythroblast cells.